Laying its flagship in 1993, Raymed strives to make significant contribution in eye health with its premium assistance in better patient care. Raymed has embarked on a new and exciting phase of its growth journey. As a widely operational pharmaceutical company, Raymed has proved its excellence in the competitive ophthalmology industry with its robust marketing infrastructure across the geographies.
A new way of thinking, Raymed is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Raymed. At Raymed, we are looking at new ways of thinking, new ways of working and new ways to touch people’s lives.
Raymed has successfully created an integrated multi-technology capability to manufacture all types of formulations with innovative and advanced technologies focusing into Preservative free Ophthalmic dosage specially for Conjunctivitis and Glaucoma Patient care, Various other formulations have been converted from suspension to solution which helps in the effective absorption, penetration and better patience compliance.
Highly skilled technicians operate multiple manufacturing facilities with the world class technology, having ultramodern equipment and machineries for manufacturing formulations in wide range of dosage forms. All are facilities are certified with WHO-GMP, ISO 9001:2008 and various International accreditations like ANVISA-Brazil, NAFDAC-Nigeria, FDB-Ghana, PMPB-Malawi amongst others.
Expanding with time Raymed has a comprehensive range of over 80 products, Raymed is a trademark owner of ophthalmic solution (eye drops), antioxidant capsules and tablets. Raymed is also into publications from last 19 years.
We are committed to the pursuit of excellence in business and in society.